T32	Treatment 259 300	trimethoprim (TMP)-sulfamethoxazole (SMX)
T33	Effect 123 232	fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia
T34	Subject 0 107	A 27-year-old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia
T35	Age 2 13	27-year-old
T36	Gender 14 17	man
T37	Sub-Disorder 39 55	bronchial asthma
T38	Drug 259 271	trimethoprim
T39	Drug 278 294	sulfamethoxazole
T41	Time_elapsed 233 248	two weeks after
T44	Sub-Disorder 57 79	eosinophilic enteritis
T45	Sub-Disorder 85 107	eosinophilic pneumonia
T31	Adverse_event 249 258	receiving
T40	Combination 277 278	-
E1	Adverse_event:T31 
E2	Combination:T40 arg:T39 arg2:T38
